{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:55:01Z","timestamp":1760151301075,"version":"build-2065373602"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1053\/j.sult.2020.02.006","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T20:49:59Z","timestamp":1583786999000},"page":"319-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Imaging of Neuromyelitis Optica Spectrum Disorders"],"prefix":"10.1053","volume":"41","author":[{"given":"Sheng-Che","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.sult.2020.02.006_bib0001","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/WNO.0000000000000396","article-title":"Finding NMO: The evolving diagnostic criteria of neuromyelitis optica","volume":"36","author":"Bennett","year":"2016","journal-title":"J Neuroophthalmol"},{"key":"10.1053\/j.sult.2020.02.006_bib0003","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1053\/j.sult.2020.02.006_bib0004","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0005","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1212\/NXI.0000000000000110","article-title":"Aquaporin-4 autoimmunity","volume":"2","author":"Zekeridou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1053\/j.sult.2020.02.006_bib0006","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0007","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn3468","article-title":"Aquaporin water channels in the nervous system","volume":"14","author":"Papadopoulos","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1053\/j.sult.2020.02.006_bib0008","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.neuroscience.2009.08.019","article-title":"Aquaporin-4 in brain and spinal cord oedema","volume":"168","author":"Saadoun","year":"2010","journal-title":"Neuroscience"},{"key":"10.1053\/j.sult.2020.02.006_bib0009","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: State-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0010","series-title":"Neuroimmune Diseases: From Cells to the Living Brain","first-page":"523","article-title":"Neuromyelitis Optica Spectrum Disorder","author":"Saadoun","year":"2019"},{"key":"10.1053\/j.sult.2020.02.006_bib0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/bpa.12099","article-title":"The pathology of an autoimmune astrocytopathy: Lessons learned from neuromyelitis optica","volume":"24","author":"Lucchinetti","year":"2014","journal-title":"Brain Pathol"},{"key":"10.1053\/j.sult.2020.02.006_bib0012","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0013","article-title":"Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status","volume":"3","author":"Mariotto","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1053\/j.sult.2020.02.006_bib0014","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp.2008.150698","article-title":"Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker","volume":"80","author":"Misu","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0015","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0016","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult Scler Int"},{"key":"10.1053\/j.sult.2020.02.006_bib0017","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0018","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/jnnp-2017-317321","article-title":"Nationwide epidemiological study of neuromyelitis optica in Japan","volume":"89","author":"Miyamoto","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0019","article-title":"Epidemiology of neuromyelitis optica in Latin America","volume":"3","author":"Alvarenga","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1053\/j.sult.2020.02.006_bib0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: An international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0021","article-title":"Neuromyelitis Optica Spectrum Disorders (NMOSD) Role of Imaging","volume":"1-17","author":"Wuerfel","year":"2019","journal-title":"Clin Neuroradiol"},{"key":"10.1053\/j.sult.2020.02.006_bib0022","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0023","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3174\/ajnr.A4539","article-title":"Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis","volume":"37","author":"Traboulsee","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/j.sult.2020.02.006_bib0024","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0025","article-title":"Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients","author":"Carnero Contentti","year":"2019","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0026","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3174\/ajnr.A5663","article-title":"Imaging differences between neuromyelitis optica spectrum disorders and multiple sclerosis: A multi-institutional study in Japan","volume":"39","author":"Tatekawa","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/j.sult.2020.02.006_bib0027","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1148\/radiol.2018172311","article-title":"Cervical Cord T1-weighted Hypointense Lesions at MR Imaging in Multiple Sclerosis: Relationship to Cord Atrophy and Disability","volume":"288","author":"Valsasina","year":"2018","journal-title":"Radiology"},{"key":"10.1053\/j.sult.2020.02.006_bib0028","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1352458516687043","article-title":"Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders","volume":"23","author":"Huh","year":"2017","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0030","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/jnnp-2014-309761","article-title":"Bright spotty lesions on the spinal cord: An additional MRI indicator of neuromyelitis optica spectrum disorder?","volume":"86","author":"Hyun","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0031","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458513495581","article-title":"\u201cBright spotty lesions\u201d on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis","volume":"20","author":"Yonezu","year":"2014","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0032","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.msard.2016.04.005","article-title":"Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction","volume":"9","author":"Kister","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2020.02.006_bib0033","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/jnnp-2016-314738","article-title":"Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders","volume":"88","author":"Zalewski","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0034","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0000000000001441","article-title":"Differential patterns of spinal cord and brain atrophy in NMO and MS","volume":"84","author":"Liu","year":"2015","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0035","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1212\/NXI.0000000000000224","article-title":"Cervical spinal cord atrophy in NMOSD without a history of myelitis or MRI-visible lesions","volume":"3","author":"Ventura","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1053\/j.sult.2020.02.006_bib0036","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneurol.2015.80","article-title":"Spinal cord MRI in multiple sclerosis\u2013diagnostic, prognostic and clinical value","volume":"11","author":"Kearney","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0037","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3174\/ajnr.A5665","article-title":"MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders","volume":"39","author":"Chien","year":"2018","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1053\/j.sult.2020.02.006_bib0038","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2016.04.007","article-title":"Spinal cord atrophy in neuromyelitis optica spectrum disorders","volume":"8","author":"Wang","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2020.02.006_bib0039","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0040","article-title":"Brain abnormalities in neuromyelitis optica spectrum disorder","volume":"2012","author":"Kim","year":"2012","journal-title":"Mult Scler Int"},{"key":"10.1053\/j.sult.2020.02.006_bib0041","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneurol.2011.249","article-title":"Brain involvement in neuromyelitis optica spectrum disorders","volume":"68","author":"Chan","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0042","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.25411","article-title":"Brain and cord imaging features in neuromyelitis optica spectrum disorders","volume":"85","author":"Cacciaguerra","year":"2019","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0043","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1177\/1352458510376640","article-title":"Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity","volume":"16","author":"Kim","year":"2010","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0044","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0b013e3182887957","article-title":"Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution","volume":"80","author":"Matthews","year":"2013","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.msard.2014.01.001","article-title":"MRI characteristics of periaqueductal lesions in multiple sclerosis","volume":"3","author":"Papadopoulou","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2020.02.006_bib0046","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/jnnp-2016-314005","article-title":"Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease","volume":"88","author":"Jurynczyk","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0047","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1053\/j.sult.2020.02.006_bib0048","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.clinimag.2015.07.027","article-title":"What do we know about brain contrast enhancement patterns in neuromyelitis optica?","volume":"40","author":"Pekcevik","year":"2016","journal-title":"Clin Imaging"},{"key":"10.1053\/j.sult.2020.02.006_bib0049","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.21753","article-title":"\"Cloud-like enhancement\" is a magnetic resonance imaging abnormality specific to neuromyelitis optica","volume":"66","author":"Ito","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2014.02.006","article-title":"Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid","volume":"269","author":"Long","year":"2014","journal-title":"J Neuroimmunol"},{"key":"10.1053\/j.sult.2020.02.006_bib0051","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1111\/j.1468-1331.2012.03696.x","article-title":"Acute reversible periependymal ventricular enhancement in neuromyelitis optica","volume":"19","author":"McGraw","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0052","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2018.11.008","article-title":"Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: A literature review","volume":"27","author":"Shahmohammadi","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2020.02.006_bib0053","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1177\/1352458509106636","article-title":"Sjogren's syndrome myelopathy: Spinal cord involvement in Sjogren's syndrome might be a manifestation of neuromyelitis optica","volume":"15","author":"Kim","year":"2009","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0054","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1352458509106228","article-title":"Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: Association with neuromyelitis optica","volume":"15","author":"Min","year":"2009","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0056","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/mus.21197","article-title":"Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica","volume":"39","author":"McKeon","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1053\/j.sult.2020.02.006_bib0057","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0058","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1352458511431728","article-title":"Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature","volume":"18","author":"Jarius","year":"2012","journal-title":"Mult Scler"},{"key":"10.1053\/j.sult.2020.02.006_bib0059","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jnnp-2013-306411","article-title":"Autoantibody biomarkers in childhood-acquired demyelinating syndromes: Results from a national surveillance cohort","volume":"85","author":"Hacohen","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clineuro.2017.02.016","article-title":"Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review","volume":"155","author":"Ran","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1053\/j.sult.2020.02.006_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-016-0787-9","article-title":"Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis","volume":"17","author":"Qin","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0062","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0063","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1007\/s00415-013-7182-x","article-title":"et al: Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis","volume":"260","author":"Zoccarato","year":"2013","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0064","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.0b013e3181dc1a7f","article-title":"NMDA receptor encephalitis mimicking seronegative neuromyelitis optica","volume":"74","author":"Kruer","year":"2010","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0065","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jneuroim.2015.02.014","article-title":"Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders","volume":"281","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1053\/j.sult.2020.02.006_bib0066","doi-asserted-by":"crossref","first-page":"e5769","DOI":"10.1097\/MD.0000000000005769","article-title":"Autoimmune diseases and HIV infection: A cross-sectional study","volume":"96","author":"Virot","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.sult.2020.02.006_bib0067","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.msard.2018.11.014","article-title":"HIV infection associated neuromyelitis optica spectrum disorder: Clinical features, imaging findings, management and outcomes","volume":"27","author":"Mathew","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2020.02.006_bib0068","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s13365-014-0260-8","article-title":"CNS demyelinating disorder with mixed features of neuromyelitis optica and multiple sclerosis in HIV-1 infection. Case report and literature review","volume":"20","author":"Delgado","year":"2014","journal-title":"J Neurovirol"},{"key":"10.1053\/j.sult.2020.02.006_bib0069","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.0b013e31822facdd","article-title":"Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children","volume":"77","author":"Langer-Gould","year":"2011","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0070","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1212\/WNL.0b013e3181f39a66","article-title":"Long-term follow-up of neuromyelitis optica with a pediatric onset","volume":"75","author":"Collongues","year":"2010","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0071","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0000000000004117","article-title":"Diagnostic algorithm for relapsing acquired demyelinating syndromes in children","volume":"89","author":"Hacohen","year":"2017","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0072","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp-2014-308550","article-title":"Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features","volume":"86","author":"Absoud","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1053\/j.sult.2020.02.006_bib0073","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1212\/WNL.0000000000002283","article-title":"Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report","volume":"86","author":"Chitnis","year":"2016","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0074","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00234-010-0755-9","article-title":"Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study","volume":"52","author":"Verhey","year":"2010","journal-title":"Neuroradiology"},{"key":"10.1053\/j.sult.2020.02.006_bib0075","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1212\/WNL.0000000000002787","article-title":"MRI in the evaluation of pediatric multiple sclerosis","volume":"87","author":"Banwell","year":"2016","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0076","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","article-title":"Acute disseminated encephalomyelitis","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0077","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1007\/s00415-017-8596-7","article-title":"What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients","volume":"264","author":"Hamid","year":"2017","journal-title":"J Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0078","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fneur.2018.00217","article-title":"MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons learned from neuromyelitis optica spectrum disorder","volume":"9","author":"Dos Passos","year":"2018","journal-title":"Front Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0079","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12974-016-0717-1","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1053\/j.sult.2020.02.006_bib0080","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.msard.2019.06.002","article-title":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008-2018: A nationwide, population-based cohort study","volume":"33","author":"Boesen","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1053\/j.sult.2020.02.006_bib0081","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: International recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1053\/j.sult.2020.02.006_bib0082","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","article-title":"Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?","volume":"30","author":"Reindl","year":"2017","journal-title":"Curr Opin Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0083","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1053\/j.sult.2020.02.006_bib0084","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1053\/j.sult.2020.02.006_bib0085","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1053\/j.sult.2020.02.006_bib0086","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0087","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1053\/j.sult.2020.02.006_bib0088","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: A comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0089","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0090","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: A multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1053\/j.sult.2020.02.006_bib0091","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1053\/j.sult.2020.02.006_bib0092","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.neurol.2018.02.084","article-title":"Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes","volume":"174","author":"Alves Do Rego","year":"2018","journal-title":"Rev Neurol (Paris)"},{"key":"10.1053\/j.sult.2020.02.006_bib0093","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/ene.12898","article-title":"Neuromyelitis optica spectrum disorders: Comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands","volume":"23","author":"van Pelt","year":"2016","journal-title":"Eur J Neurol"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217120300147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887217120300147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:23:24Z","timestamp":1760135004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887217120300147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0887217120300147"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2020.02.006","relation":{},"ISSN":["0887-2171"],"issn-type":[{"type":"print","value":"0887-2171"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of Neuromyelitis Optica Spectrum Disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Ultrasound, CT and MRI","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sult.2020.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}